67 related articles for article (PubMed ID: 1448379)
21. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
22. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenals.
Sasano H; Sasano N; Okamoto M
Pathol Res Pract; 1989 Mar; 184(3):337-42. PubMed ID: 2748459
[TBL] [Abstract][Full Text] [Related]
24. Steroid contents and cortical steroidogenic enzymes in non-hyperfunctioning adrenal adenoma.
Suzuki H; Shibata H; Takita T; Wakino S; Ogishima T; Ishimura Y; Saruta T
Endocr J; 1994 Jun; 41(3):267-74. PubMed ID: 7951578
[TBL] [Abstract][Full Text] [Related]
25. Steroid 21-hydroxylase and 17 alpha-hydroxylase in microsomal fraction of functioning adrenocortical tumors.
Naganuma H; Sasano N
Tohoku J Exp Med; 1989 Jul; 158(3):253-62. PubMed ID: 2799809
[TBL] [Abstract][Full Text] [Related]
26. 11 beta-Hydroxylase in mitochondrial fractions of functioning and non-functioning adrenocortical tumors.
Naganuma H; Ojima M; Sasano N
Tohoku J Exp Med; 1988 May; 155(1):81-96. PubMed ID: 3261901
[TBL] [Abstract][Full Text] [Related]
27. Adrenocortical tumor in a patient with untreated congenital adrenocortical hyperplasia owing to 21-hydroxylase deficiency: characterization of steroidogenic lesions.
Takayama K; Ohashi M; Haji M; Matsumoto T; Mihara Y; Kumazawa J; Kato K
J Urol; 1988 Oct; 140(4):803-5. PubMed ID: 3418804
[TBL] [Abstract][Full Text] [Related]
28. Steroid biosynthesis in human adrenal tumors.
D'Agata R; Malozowski S; Barkan A; Cassorla F; Loriaux D
Horm Metab Res; 1987 Aug; 19(8):386-8. PubMed ID: 3499371
[TBL] [Abstract][Full Text] [Related]
29. Decreased levels of steroid 21-hydroxylase [P450(c21)] and its mRNA in an adrenocortical adenoma associated with 21-hydroxylase deficiency.
Haji M; Ogo A; Ohashi M; Sekiya K; Takayanagi R; Takayama K; Kumazawa J; Nawata H
Endocrinol Jpn; 1990 Dec; 37(6):841-50. PubMed ID: 2101789
[TBL] [Abstract][Full Text] [Related]
30. [Endocrine pathological analysis of primary pigmented nodular adrenocortical disease].
Sasano H; Shimizu S; Funahashi H; Demura H
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):31-6. PubMed ID: 7958081
[TBL] [Abstract][Full Text] [Related]
31. ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma.
Kitamura T; Blinder AR; Nanba K; Tsuiki M; Mishina M; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yoneyama K; Udager AM; Rainey WE; Yasoda A; Satoh-Asahara N; Tagami T
Eur J Endocrinol; 2022 Dec; 187(6):K39-K45. PubMed ID: 36691941
[TBL] [Abstract][Full Text] [Related]
32. Localization of steroidogenic enzymes in adrenal cortex and its disorders.
Sasano H
Endocr J; 1994 Oct; 41(5):471-82. PubMed ID: 7889106
[TBL] [Abstract][Full Text] [Related]
33. Non-functioning adrenocortical carcinoma arising in an adrenal rest: immunohistochemical study of an adult patient.
Yokoyama H; Adachi T; Tsubouchi K; Tanaka M; Sasano H
Tohoku J Exp Med; 2013 Apr; 229(4):267-70. PubMed ID: 23603421
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen producing adrenocortical adenoma: clinical, biochemical and immunohistochemical studies.
Goto T; Murakami O; Sato F; Haraguchi M; Yokoyama K; Sasano H
Clin Endocrinol (Oxf); 1996 Nov; 45(5):643-8. PubMed ID: 8977764
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein lipase promoting agent, NO-1886, modulates adrenal functions: species difference in effects of NO-1886 on steroidogenesis.
Shimono K; Tsutsumi K; Yaguchi H; Omura M; Sasano H; Nishikawa T
Steroids; 1999 Jul; 64(7):453-9. PubMed ID: 10443901
[TBL] [Abstract][Full Text] [Related]
36. Incomplete Pattern of Steroidogenic Protein Expression in Functioning Adrenocortical Carcinomas.
Pereira SS; Costa MM; Gomez-Sanchez CE; Monteiro MP; Pignatelli D
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751564
[TBL] [Abstract][Full Text] [Related]
37. Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism.
Lefebvre H; Prévost G; Louiset E
Eur J Endocrinol; 2013 Nov; 169(5):R115-38. PubMed ID: 23956298
[TBL] [Abstract][Full Text] [Related]
38. New approaches in human adrenocortical pathology: Assessment of adrenocortical function in surgical specimen of human adrenal glands.
Sasano H
Endocr Pathol; 1992 Mar; 3(1):4-13. PubMed ID: 32357628
[TBL] [Abstract][Full Text] [Related]
39. Adrenal rest tumor of the liver: a case report with immunohistochemical investigation of steroidogenesis.
Arai K; Muro H; Suzuki M; Oba N; Ito K; Sasano H
Pathol Int; 2000 Mar; 50(3):244-8. PubMed ID: 10792789
[TBL] [Abstract][Full Text] [Related]
40. A case of estrogen-secreting adrenocortical carcinoma: Comprehensive immunohistochemical analysis of disorganized steroid genesis.
Yokoyama M; Kijima T; Takada-Owada A; Sakamoto K; Suzuki I; Nishihara D; Nakamura Y; Ishida K; Kamai T
IJU Case Rep; 2021 Sep; 4(5):318-321. PubMed ID: 34497994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
